Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Cefazolin on Preventing Port-Site Infection in Cancer Patients
IRCT20260619069875N1Phase 3Recruiting
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2026
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cefazolin in catheter infection and surgical site infection (SSI), sponsored by Arak University of Medical Sciences. Started Jul 2026; status: recruiting.
02
Drugs
cefazolin
03
Conditions
catheter infectionsurgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20260619069875N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260619069875N1.